ganirelix
Selected indexed studies
- Ganirelix. (Drugs, 2000) [PMID:10718102]
- Ganirelix and the prevention of premature luteinizing hormone surges. (F S Rep, 2023) [PMID:37223764]
- Ganirelix acetate. (Am J Health Syst Pharm, 1999) [PMID:10582819]
_Worker-drafted node — pending editorial review._
Connections
ganirelix is a side effect of
Sources
- GnRH antagonists. (2000) pubmed
- Ganirelix. (2000) pubmed
- Ganirelix and the prevention of premature luteinizing hormone surges. (2023) pubmed
- Ganirelix acetate. (1999) pubmed
- The gonadotrophin-releasing hormone antagonist ganirelix--history and introductory data. (2002) pubmed
- Effects of metformin and ganirelix on subcutaneous endometriosis in a mouse model of autophagy-related cell death. (2023) pubmed
- Post-marketing safety profile of ganirelix in women: a 20-year pharmacovigilance analysis of global adverse drug event databases (2004-2024). (2025) pubmed
- Medroxyprogesterone acetate versus ganirelix in oocyte donation: a randomized controlled trial. (2019) pubmed
- Synthesis and characterization of two potential impurities (des-ethyl-Ganirelix) generated in the Ganirelix manufacturing process. (2023) pubmed
- Comparison of pregnancy outcomes and safety between cetrorelix and ganirelix in IVF/ICSI antagonist protocols: a retrospective cohort study. (2025) pubmed